Porto Joao G, Raymo Adele, Suarez Arbelaez Maria Camila, Gurayah Aaron A, Ramasamy Ranjith
Desai Sethi Urology Institute, University of Miami, Miami, USA.
Department of Pediatric Urology, Nicklaus Children's Hospital, Miami, USA.
Cureus. 2023 Aug 29;15(8):e44349. doi: 10.7759/cureus.44349. eCollection 2023 Aug.
The long-term outcomes of varicocelectomy in adolescents is debated. The aim of this study was to evaluate symptom improvement, hypogonadism, and paternity in those who underwent adolescent sub-inguinal microscopic varicocelectomy.
A retrospective chart review was done of adolescents (median=19, interquartile range (IQR)=16-19.75 years) who underwent microscopic varicocelectomy between 2011 and 2021. Demographics, surgical indications, and outcomes were collected, as well as pre- and postoperative hormone levels and semen parameters. A questionnaire was prospectively collected to evaluate orchialgia, paternity, and symptoms of hypogonadism. Descriptive statistics and t-tests were performed, with significance assessed at p-value < 0.05.
A total of 46 adolescents were included. Age at the time of diagnosis and surgery was 19 (IQR=16-20) and 19 (IQR= 18-21) years, respectively. Follicle-stimulating hormone (FSH), luteinizing hormone (LH), and total testosterone were not affected after surgery. Similarly, semen parameters were preserved after varicocelectomy, with median concentration increasing from 12x10/ml to 16x10/ml but not reaching significance (p=0.272). A total of 26 men completed the questionnaire. The age of responders was 22 (IQR=21-24) years, and the time after having had the varicocelectomy was 36.5 (IQR= 18.25-62.25) months. Orchialgia persisted in five men, and three reported having a recurrence. Two men, who had a preoperative abnormal semen analysis, were actively trying to have children and reported successfully having achieved natural pregnancies. None of the patients reported having hypogonadism, and none were receiving testosterone therapy.
Our study suggests that microscopic varicocelectomy in adolescents appears to be a safe and feasible procedure with a low rate of syndrome recurrence and no association with symptoms or biochemical evidence of hypogonadism.
青少年精索静脉曲张切除术的长期疗效存在争议。本研究的目的是评估接受青少年腹股沟下显微精索静脉曲张切除术患者的症状改善情况、性腺功能减退及生育情况。
对2011年至2021年间接受显微精索静脉曲张切除术的青少年(中位数=19岁,四分位间距(IQR)=16 - 19.75岁)进行回顾性病历审查。收集人口统计学资料、手术指征及结果,以及术前和术后的激素水平及精液参数。前瞻性收集一份问卷以评估睾丸疼痛、生育情况及性腺功能减退症状。进行描述性统计和t检验,p值<0.05时评估为有统计学意义。
共纳入46名青少年。诊断和手术时的年龄分别为19岁(IQR = 16 - 20)和19岁(IQR = 18 - 21)。术后促卵泡生成素(FSH)、促黄体生成素(LH)和总睾酮未受影响。同样,精索静脉曲张切除术后精液参数得以保留,中位数浓度从12×10⁶/ml增至16×10⁶/ml,但未达到统计学意义(p = 0.272)。共有26名男性完成问卷。应答者年龄为22岁(IQR = 21 - 24),精索静脉曲张切除术后时间为36.5个月(IQR = 18.25 - 62.25)。5名男性仍有睾丸疼痛,3名报告复发。2名术前精液分析异常的男性积极尝试生育并报告成功自然受孕。无患者报告有性腺功能减退,也无人接受睾酮治疗。
我们的研究表明,青少年显微精索静脉曲张切除术似乎是一种安全可行的手术,综合征复发率低,且与性腺功能减退的症状或生化证据无关。